SARS-COV-2 Vaccinations in RMD patients
The EULAR Task Force on COVID-19 has updated the EULAR View-points on SARS-CoV-2 vaccination in patients with RMDs (December 2021).
The information addresses questions, including considerations regarding vaccination effectiveness and safety, the third vaccination dose, booster vaccination, combination with Influenza and Pneumococcus vaccination, among other frequently asked questions by people with RMDs.
EULAR President, Prof Annamaria Iagnocco, invites you to share the link with your axSpA community.
Other NEWS
New Member Resources Webpages
ASIF are delighted that our new resources webpages are now …
Read More
Member Webinars
Community/Direct Fundraising Tuesday 21 March at 18:00-19:00 GMT Fundraising, specifically direct or …
Read More
ACR Report
Michael Mallinson attended the American College of Rheumatology (ACR) Convergence …
Read More